The redox basis of epigenetic modifications: From mechanisms to functional consequences

Antioxidants and Redox Signaling

Volumn 15, Issue 2, 2011, Pages 551-589

  Cyr, Anthony R ^a   Domann, Frederick E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYGLUTARIC ACID; 2 OXOGLUTARIC ACID; ADENOSINE DIPHOSPHATE RIBOSE; ALCOHOL; ASCORBIC ACID; DNA; DNA METHYLTRANSFERASE; ENZYME; GLUTATHIONE; GLYCOGEN SYNTHASE KINASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; HOMOCYSTEINE; METHIONINE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PARACETAMOL; POLY(ADENOSINE DIPHOSPHATE RIBOSE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; RNA; S ADENOSYLMETHIONINE; SIRTUIN; SIRTUIN 1;

ACETYLATION; ACUTE GRANULOCYTIC LEUKEMIA; ADENOSINE DIPHOSPHATE RIBOSYLATION; ALZHEIMER DISEASE; BIOSYNTHESIS; BRAIN TUMOR; CALORIC RESTRICTION; CELL MEMBRANE; CHROMATIN STRUCTURE; CITRIC ACID CYCLE; COGNITIVE DEFECT; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GLIOMA; HISTONE ACETYLATION; HISTONE METHYLATION; HOMEOSTASIS; HUMAN; IRON METABOLISM; LEIGH DISEASE; LIVER DISEASE; NEOPLASM; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN TENSION; PATHOGENESIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

EID: 79959521749     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3492     Document Type: Review

References (353)

1. Ackrell BA. Cytopathies involving mitochondrial complex II. Mol Aspects Med 23: 369-384, 2002. (Pubitemid 35286652)
2. Aghili M, Zahedi F, and Rafiee E. Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J Neurooncol 91: 233-236, 2009.
3. Ahringer J. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet 16: 351-356, 2000. (Pubitemid 30628836)
4. Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, et al. New nomenclature for chromatin-modifying enzymes. Cell 131: 633-636, 2007. (Pubitemid 350089969)
5. Althaus FR, Hofferer L, Kleczkowska HE, Malanga M, Naegeli H, Panzeter PL, and Realini CA. Histone shuttling by poly ADP-ribosylation. Mol Cell Biochem 138: 53-59, 1994. (Pubitemid 24365395)
6. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Cohen H, Lin SS, Manchester JK, Gordon JI, and Sinclair DA. Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels. J Biol Chem 277: 18881-18890, 2002. (Pubitemid 34952448)
7. Anekonda TS and Reddy PH. Neuronal protection by sirtuins in Alzheimer's disease. J Neurochem 96: 305-313, 2006.
8. Anzilotti C, Pratesi F, Tommasi C, and Migliorini P. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev 9: 158-160, 2010.
9. Avery OT, Macleod CM, and McCarty M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 79: 137-158, 1944.
10. Avila MA, Berasain C, Torres L, Martin-Duce A, Corrales FJ, Yang H, Prieto J, Lu SC, Caballeria J, Rodes J, et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 33: 907-914, 2000.
11. Ayoub N, Noma K, Isaac S, Kahan T, Grewal SI, and Cohen A. A novel jmjC domain protein modulates heterochromatization in fission yeast. Mol Cell Biol 23: 4356-4370, 2003. (Pubitemid 36666436)
12. Barak AJ, Beckenhauer HC, and Tuma DJ. Methionine synthase. a possible prime site of the ethanolic lesion in liver. Alcohol 26: 65-67, 2002. (Pubitemid 34462228)
13. Berchner-Pfannschmidt U, Tug S, Kirsch M, and Fandrey J. Oxygen-sensing under the influence of nitric oxide. Cell Signal 22: 349-356, 2010.
14. Berchner-Pfannschmidt U, Yamac H, Trinidad B, and Fandrey J. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J Biol Chem 282: 1788-1796, 2007. (Pubitemid 47076719)
15. Berger SJ, Sudar DC, and Berger NA. Metabolic consequences of DNA damage: DNA damage induces alterations in glucose metabolism by activation of poly (ADP-ribose) polymerase. Biochem Biophys Res Commun 134: 227-232, 1986. (Pubitemid 16145323)
16. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 9: 2395-2402, 2000.
17. Bilsborough J, Van Pel A, Uyttenhove C, Boon T, and Van den Eynde BJ. Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815. J Immunol 162: 3534-3540, 1999. (Pubitemid 29313606)
18. Bird A. Perceptions of epigenetics. Nature 447: 396-398, 2007. (Pubitemid 46816744)
19. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, and Sinclair DA. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 277: 45099-45107, 2002. (Pubitemid 36159111)
20. Bogdanovic O and Veenstra GJ. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 118: 549-565, 2009.
21. Bohm L, Schneeweiss FA, Sharan RN, and Feinendegen LE. Influence of histone acetylation on the modification of cytoplasmic and nuclear proteins by ADP-ribosylation in response to free radicals. Biochim Biophys Acta 1334: 149-154, 1997. (Pubitemid 27117516)
22. Brahmachari HD and Joseph S. Cobalt compounds for the control of hypoxic stress. Aerosp Med 44: 636-638, 1973.
23. Brickell KL, Leverenz JB, Steinbart EJ, Rumbaugh M, Schellenberg GD, Nochlin D, Lampe TH, Holm IE, Van Deerlin V, Yuan W, et al. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease. J Neurol Neurosurg Psychiatry 78: 1050-1055, 2007.
24. Broday L, Peng W, Kuo MH, Salnikow K, Zoroddu M, and Costa M. Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res 60: 238-241, 2000. (Pubitemid 30070741)
25. Brunengraber H. Alpha-ketoglutarate is the precursor of L-2-hydroxyglutarate. J Inherit Metab Dis 30: 628, 2007.
26. Brunengraber H and Roe CR. Anaplerotic molecules: current and future. J Inherit Metab Dis 29: 327-331, 2006. (Pubitemid 43880628)
27. Bubber P, Haroutunian V, Fisch G, Blass JP, and Gibson GE. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57: 695-703, 2005. (Pubitemid 40628858)
28. Bunik VI. 2-Oxo acid dehydrogenase complexes in redox regulation. Eur J Biochem 270: 1036-1042, 2003.
29. Burns A and Iliffe S. Alzheimer's disease. BMJ 338: b158, 2009.
30. Callapina M, Zhou J, Schnitzer S, Metzen E, Lohr C, Deitmer JW, and Brune B. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation - implications for prolyl hydroxylase activity and iron. Exp Cell Res 306: 274-284, 2005. (Pubitemid 40692790)
31. Campanero MR, Armstrong MI, and Flemington EK. CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci U S A 97: 6481-6486, 2000. (Pubitemid 30412739)
32. Cao D, Tal TL, Graves LM, Gilmour I, Linak W, Reed W, Bromberg PA, and Samet JM. Diesel exhaust particulateinduced activation of Stat3 requires activities of EGFR and Src in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 292: L422-L429, 2007.
33. Cardoso SM, Santos S, Swerdlow RH, and Oliveira CR. Functional mitochondria are required for amyloid betamediated neurotoxicity. FASEB J 15: 1439-1441, 2001.
34. Castro L, Rodriguez M, and Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 269: 29409-29415, 1994. (Pubitemid 24365085)
35. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, Blom HJ, Jakobs C, and Tavares de Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 49: 1292-1296, 2003. (Pubitemid 36900615)
36. Cederbaum AI. Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury. World J Gastroenterol 16: 1366-1376, 2010.
37. Cervera AM, Bayley JP, Devilee P, and McCreath KJ. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol Cancer 8, 2009.
38. Chambon P, Weill JD, and Mandel P. Nicotinamide mononucleotide activation of new DNA-dependent poly-adenylic acid synthesizing nuclear enzyme. Biochem Biophys Res Commun 11: 39-43, 1963.
39. Chang B, Chen Y, Zhao Y, and Bruick RK. JMJD6 is a histone arginine demethylase. Science 318: 444-447, 2007. (Pubitemid 47614528)
40. Chang X and Fang K. PADI4 and tumourigenesis. Cancer Cell Int 10: 7, 2010.
41. Chen H, Ke Q, Kluz T, Yan, Y, and Costa M. Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol Cell Biol 26: 3728-3737, 2006. (Pubitemid 43726391)
42. Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A 104: 8749-8754, 2007. (Pubitemid 47175383)
43. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko, J, and Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A 105: 11105-11109, 2008.
44. Chen Z, Li Y, Zhang H, Huang P, and Luthra R. Hypoxiaregulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29: 4362-4368, 2010.
45. Cheng Y, Liu X, Zhang S, Lin Y, Yang J, and Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47: 5-14, 2009.
46. Chouliaras L, Rutten BP, Kenis G, Peerbooms O, Visser PJ, Verhey F, van Os J, Steinbusch HW, and van den Hove DL. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol 90: 498-510, 2010.
47. Costa FF. Non-coding RNAs, epigenetics and complexity. Gene 410: 9-17, 2008.
48. Costa M, Davidson TL, Chen H, Ke Q, Zhang P, Yan Y, Huang C, and Kluz T. Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res 592: 79-88, 2005. (Pubitemid 41714046)
49. Couture JF, Collazo E, Ortiz-Tello PA, Brunzelle JS, and Trievel RC. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nat Struct Mol Biol 14: 689-695, 2007. (Pubitemid 47220059)
50. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, and Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem 275: 25122-25129, 2000.
51. Cullen JJ. Ascorbate induces autophagy in pancreatic cancer. Autophagy 6: 421-422, 2010.
52. Cuthbert GL, Daujat S, Snowden AW, Erdjument-Bromage H, Hagiwara T, Yamada M, Schneider R, Gregory PD, Tempst P, Bannister AJ, et al. Histone deimination antagonizes arginine methylation. Cell 118: 545-553, 2004. (Pubitemid 39179708)
53. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462: 739-744, 2009.
54. Dantzer F, de La Rubia G, Menissier-De Murcia J, Hostomsky Z, de Murcia G, and Schreiber V. Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1. Biochemistry 39: 7559-7569, 2000. (Pubitemid 30422075)
55. de Capoa A, Febbo FR, Giovannelli F, Niveleau A, Zardo G, Marenzi S, and Caiafa P. Reduced levels of poly(ADP-ribosyl)ation result in chromatin compaction and hypermethylation as shown by cell-by-cell computer-assisted quantitative analysis. FASEB J 13: 89-93, 1999. (Pubitemid 29038278)
56. De Luca A, Sacchetta P, Nieddu M, Di Ilio, C and Favaloro B. Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter. BMC Mol Biol 8: 39, 2007.
57. de Murcia G, Huletsky A, Lamarre D, Gaudreau A, Pouyet J, Daune M, and Poirier GG. Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation. J Biol Chem 261: 7011-7017, 1986. (Pubitemid 17219474)
58. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8: 705-713, 2008.
59. Deubzer B, Mayer F, Kuci Z, Niewisch M, Merkel G, Handgretinger R, and Bruchelt G. H(2)O(2)-mediated cytotoxicity of pharmacologic ascorbate concentrations to neuroblastoma cells: potential role of lactate and ferritin. Cell Physiol Biochem 25: 767-774, 2010.
60. Di Pietro G, Magno LA, and Rios-Santos F. Glutathione Stransferases: an overview in cancer research. Expert Opin Drug Metab Toxicol 6: 153-170, 2010.
61. Dillon SC, Zhang X, Trievel RC, and Cheng X. The SETdomain protein superfamily: protein lysine methyltrans-ferases. Genome Biol 6: 227, 2005.
62. Dje N'Guessan P, Riediger F, Vardarova K, Scharf S, Eitel J, Opitz B, Slevogt H, Weichert W, Hocke AC, Schmeck B, et al. Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. Arterioscler Thromb Vasc Biol 29: 380-386, 2009.
63. Domann FE, Rice JC, Hendrix MJ, and Futscher BW. Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85: 805-810, 2000. (Pubitemid 30131470)
64. Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D, and Phang JM. Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res 61: 1810-1815, 2001. (Pubitemid 32691989)
65. Doyle, K and Fitzpatrick FA. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Biol Chem 285: 17417-17424, 2010.
66. Duce AM, Ortiz P, Cabrero C, and Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 8: 65-68, 1988. (Pubitemid 18092060)
67. Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, and Sedgwick B. Reversal of DNA alkylation damage by two human dioxygenases. Proc Natl Acad Sci U S A 99: 16660-16665, 2002. (Pubitemid 36034029)
68. Ecker JR and Davis RW. Inhibition of gene expression in plant cells by expression of antisense RNA. Proc Natl Acad Sci U S A 83: 5372-5376, 1986. (Pubitemid 16001224)
69. El Ramy R, Magroun N, Messadecq N, Gauthier LR, Boussin FD, Kolthur-Seetharam U, Schreiber V, McBurney MW, Sassone-Corsi P, and Dantzer F. Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes. Cell Mol Life Sci 66: 3219-3234, 2009.
70. Estiu G, West N, Mazitschek R, Greenberg E, Bradner JE, and Wiest O. On the inhibition of histone deacetylase 8. Bioorg Med Chem 18: 4103-4110, 2010.
71. Falnes PO, Johansen RF, and Seeberg E. AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature 419: 178-182, 2002. (Pubitemid 35025447)
72. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS ONE 5: e10345, 2010.
73. Favier J, Briere JJ, Burnichon N, Riviere J, Vescovo L, Benit P, Giscos-Douriez I, De Reynies A, Bertherat J, Badoual C, et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS ONE 4: e7094, 2009.
74. Feinberg AP, Ohlsson R, and Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 7: 21-33, 2006. (Pubitemid 41828945)
75. Fernandez-Checa JC, Colell A, and Garcia-Ruiz C. S-Adenosyl-L-methionine and mitochondrial reduced glutathione depletion in alcoholic liver disease. Alcohol 27: 179-183, 2002. (Pubitemid 34876920)
76. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol 39: 223-235, 2008.
77. Flashman E, Davies SL, Yeoh KK, and Schofield CJ. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents. Biochem J 427: 135-142, 2010.
78. Flint DH, Tuminello JF, and Emptage MH. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 268: 22369-22376, 1993. (Pubitemid 23318282)
79. Forneris F, Battaglioli E, Mattevi A, and Binda C. New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin. FEBS J 276: 4304-4312, 2009.
80. Forneris F, Binda C, Vanoni MA, Mattevi A, and Battaglioli E. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett 579: 2203-2207, 2005. (Pubitemid 40469693)
81. Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, Ye W, Zhou X, and Jones PA. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 69: 2623-2629, 2009.
82. Fry I. The Role of natural selection in the origin of life. Orig Life Evol Biosph 41: 3-16, 2011.
83. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 260: 273-279, 1999. (Pubitemid 29351819)
84. Fujita N, Watanabe S, Ichimura T, Tsuruzoe S, Shinkai Y, Tachibana M, Chiba T, and Nakao M. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 hetero-chromatic complex for DNA methylation-based transcriptional repression. J Biol Chem 278: 24132-24138, 2003. (Pubitemid 36830249)
85. Fuks F, Hurd PJ, Deplus R, and Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 31: 2305-2312, 2003. (Pubitemid 37442098)
86. Futscher BW, O'Meara MM, Kim CJ, Rennels MA, Lu D, Gruman LM, Seftor RE, Hendrix MJ, and Domann FE. Aberrant methylation of the maspin promoter is an early event in human breast cancer. Neoplasia 6: 380-389, 2004. (Pubitemid 38924853)
87. Gantt SL, Gattis SG, and Fierke CA. Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion. Biochemistry 45: 6170-6178, 2006. (Pubitemid 43727109)
88. Gao YS, Hubbert CC, and Yao TP. The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation. J Biol Chem 285: 11219-11226, 2010.
89. Gardner PR and Fridovich I. Superoxide sensitivity of the Escherichia coli aconitase. J Biol Chem 266: 19328-19333, 1991. (Pubitemid 21908236)
90. Gardner PR, Raineri I, Epstein LB, and White CW. Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem 270: 13399-13405, 1995.
91. Gatz M, Fratiglioni L, Johansson B, Berg S, Mortimer JA, Reynolds CA, Fiske A, and Pedersen NL. Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiol Aging 26: 439-447, 2005. (Pubitemid 40093927)
92. Gatz M, Mortimer JA, Fratiglioni L, Johansson B, Berg S, Reynolds CA, and Pedersen NL. Potentially modifiable risk factors for dementia in identical twins. Alzheimers Dement 2: 110-117, 2006.
93. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, and Pedersen NL. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63: 168-174, 2006. (Pubitemid 43213878)
94. Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, Rotig A, and Jeunemaitre X. The R22 × mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 69: 1186-1197, 2001. (Pubitemid 33124200)
95. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, and Jeunemaitre X. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochro-mocytomas. Cancer Res 63: 5615-5621, 2003. (Pubitemid 37139886)
96. Golderer G and Grobner P. ADP-ribosylation of core histones and their acetylated subspecies. Biochem J 277(Pt 3): 607-610, 1991.
97. Grant S. Targeting histone demethylases in cancer therapy. Clin Cancer Res 15: 7111-7113, 2009.
98. Green A and Beer P. Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med 362: 369-370, 2010.
99. Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, and LaFerla FM. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28: 11500-11510, 2008.
100. Gregoretti IV, Lee YM, and Goodson HV. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. JMol Biol 338: 17-31, 2004. (Pubitemid 38429783)
101. Grewal SI. RNAi-dependent formation of heterochromatin and its diverse functions. Curr Opin Genet Dev 20: 134-141, 2010.
102. Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG, Sasaki M, Jin S, Schenkein DP, Su SM, et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 207: 339-344, 2010.
103. Guarente L. Calorie restriction and SIR2 genes - towards a mechanism. Mech Ageing Dev 126: 923-928, 2005. (Pubitemid 41033172)
104. Haigis MC and Guarente LP. Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913-2921, 2006. (Pubitemid 44771725)
105. Hajkova P, Jeffries SJ, Lee C, Miller N, Jackson SP, and Surani MA. Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. Science 329: 78-82, 2010.
106. Hakme A, Wong HK, Dantzer F, and Schreiber V. The expanding field of poly(ADP-ribosyl)ation reactions. "Protein modifications: beyond the usual suspects" Review Series. EMBO Rep 9: 1094-1100, 2008.
107. Haliloglu G, Jobard F, Oguz KK, Anlar B, Akalan N, Coskun T, Sass JO, Fischer, J, and Topcu M. L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings. Neuropediatrics 39: 119-122, 2008.
108. Hallows WC, Smith BC, Lee S, and Denu JM. Ure(k)a! Sirtuins Regulate Mitochondria. Cell 137: 404-406, 2009.
109. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325: 1139-1142, 2009.
110. Hassa PO, Haenni SS, Elser M, and Hottiger MO. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70: 789-829, 2006. (Pubitemid 44484693)
111. Hassa PO and Hottiger MO. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 13: 3046-3082, 2008. (Pubitemid 351589219)
112. Hausladen A and Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 269: 29405-29408, 1994. (Pubitemid 24365084)
113. Hawkins PG, Santoso S, Adams C, Anest V, and Morris KV. Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res 37: 2984-2995, 2009.
114. Hediger MA. New view at C. Nat Med 8: 445-446, 2002. (Pubitemid 34546739)
115. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112, 2009.
116. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, et al. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277: 26351-26355, 2002. (Pubitemid 34967127)
117. Hipkiss AR. Energy metabolism, altered proteins, sirtuins and ageing: converging mechanisms? Biogerontology 9: 49-55, 2008.
118. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-3023, 2001. (Pubitemid 32323483)
119. Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, and Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278: 30772-30780, 2003. (Pubitemid 36994584)
120. Hitchler MJ and Domann FE. An epigenetic perspective on the free radical theory of development. Free Radic Biol Med 43: 1023-1036, 2007. (Pubitemid 47302657)
121. Hitchler MJ and Domann FE. Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radic Biol Med 47: 115-127, 2009.
122. Hitchler MJ, Wikainapakul K, Yu L, Powers K, Attatippaholkun W, and Domann FE. Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells. Epigenetics 1: 163-171, 2006.
123. Holliday R. The inheritance of epigenetic defects. Science 238: 163-170, 1987. (Pubitemid 17139717)
124. Huang Y, Myers SJ, and Dingledine R. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat Neurosci 2: 867-872, 1999. (Pubitemid 30602598)
125. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, and Yao TP. HDAC6 is a microtubule-associated deacetylase. Nature 417: 455-458, 2002. (Pubitemid 34563539)
126. Hyun DH, Hernandez JO, Mattson MP, and de Cabo R. The plasma membrane redox system in aging. Ageing Res Rev 5: 209-220, 2006. (Pubitemid 43766257)
127. Iguchi-Ariga SM and Schaffner W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGT-CA abolishes specific factor binding as well as transcriptional activation. Genes Dev 3: 612-619, 1989.
128. Illingworth RS and Bird AP. CpG islands - "a rough guide." FEBS Lett 583: 1713-1720, 2009.
129. Imai S, Armstrong CM, Kaeberlein M, and Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800, 2000. (Pubitemid 30111843)
130. Ingrosso D and Perna AF. Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim Biophys Acta 1790: 892-899, 2009.
131. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8: 143-153, 2005. (Pubitemid 41132743)
132. Ito K, Hanazawa T, Tomita K, Barnes PJ, and Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 315: 240-245, 2004. (Pubitemid 38175212)
133. James LP, Mayeux PR, and Hinson JA. Acetaminopheninduced hepatotoxicity. Drug Metab Dispos 31: 1499-1506, 2003.
134. Jeltsch A. On the enzymatic properties of Dnmt1: specificity, processivity, mechanism of linear diffusion and allosteric regulation of the enzyme. Epigenetics 1: 63-66, 2006.
135. Jeninga EH, Schoonjans K, and Auwerx J. Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene 29: 4617-4624, 2010.
136. Jensen TJ, Novak P, Wnek SM, Gandolfi AJ, and Futscher BW. Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells. Toxicol Appl Pharmacol 241: 221-229, 2009.
137. Jensen TJ, Wozniak RJ, Eblin KE, Wnek SM, Gandolfi AJ, and Futscher BW. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol Appl Pharmacol 235: 39-46, 2009.
138. Jenuwein T and Allis CD. Translating the histone code. Science 293: 1074-1080, 2001. (Pubitemid 32758077)
139. Jenuwein T, Laible G, Dorn R, and Reuter G. SET domain proteins modulate chromatin domains in eu- and heterochromatin. Cell Mol Life Sci 54: 80-93, 1998. (Pubitemid 28048252)
140. Jones JE, Causey CP, Knuckley B, Slack-Noyes JL, and Thompson PR. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr Opin Drug Discov Devel 12: 616-627, 2009.
141. Julien C, Tremblay C, Emond V, Lebbadi M, Salem N Jr., Bennett DA, and Calon F. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68: 48-58, 2009.
142. Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, and Yao TP. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115: 727-738, 2003. (Pubitemid 38030301)
143. Kawai K, Li YS, Song MF, and Kasai H. DNA methylation by dimethyl sulfoxide and methionine sulfoxide triggered by hydroxyl radical and implications for epigenetic modifications. Bioorg Med Chem Lett 20: 260-265, 2010.
144. Kharbanda KK. Role of transmethylation reactions in alcoholic liver disease. World J Gastroenterol 13: 4947-4954, 2007. (Pubitemid 47496826)
145. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26: 3169-3179, 2007. (Pubitemid 47057498)
146. Kim JS and Shukla SD. Histone h3 modifications in rat hepatic stellate cells by ethanol. Alcohol Alcohol 40: 367-372, 2005. (Pubitemid 41222394)
147. Kim JS and Shukla SD. Acute in vivo effect of ethanol (binge drinking) on histone H3 modifications in rat tissues. Alcohol Alcohol 41: 126-132, 2006.
148. King A, Selak MA, and Gottlieb E. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25: 4675-4682, 2006. (Pubitemid 44187617)
149. Kirkland JB. Niacin status impacts chromatin structure. J Nutr 139: 2397-2401, 2009.
150. Knowles HJ, Raval RR, Harris AL, and Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63: 1764-1768, 2003. (Pubitemid 36460834)
151. Kolthur-Seetharam U, Dantzer F, McBurney MW, de Murcia G, and Sassone-Corsi P. Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle 5: 873-877, 2006. (Pubitemid 44145583)
152. Komotar RJ, Starke RM, Sisti MB, and Connolly ES. IDH1 and IDH2 mutations in gliomas and the associated induction of hypoxia-inducible factor and production of 2-hydroxyglutarate. Neurosurgery 66: N20-N21, 2010.
153. Konijn AM, Glickstein H, Vaisman B, Meyron-Holtz EG, Slotki IN, and Cabantchik ZI. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood 94: 2128-2134, 1999. (Pubitemid 29430430)
154. Kouzarides T. Chromatin modifications and their function. Cell 128: 693-705, 2007. (Pubitemid 46273577)
155. Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, Yoshida M, Toft DO, Pratt WB, and Yao TP. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 18: 601-607, 2005. (Pubitemid 40726236)
156. Koziol MJ and Rinn JL. RNA traffic control of chromatin complexes. Curr Opin Genet Dev 20: 142-148, 2010.
157. Kriaucionis S and Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324: 929-930, 2009.
158. Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res 531: 81-92, 2003. (Pubitemid 37456724)
159. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, et al. A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867, 2007.
160. Kuo MH and Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20: 615-626, 1998. (Pubitemid 28422221)
161. Kutty RK, Samuel W, Jaworski C, Duncan T, Nagineni CN, Raghavachari N, Wiggert B, and Redmond TM. MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl)retinamide. Mol Vis 16: 1475-1486, 2010.
162. Lachner M, O'Carroll D, Rea S, Mechtler K, and Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120, 2001. (Pubitemid 32225847)
163. Lal G, Padmanabha L, Provenzano M, Fitzgerald M, Weydert J, and Domann FE. Regulation of 14-3-3 sigma expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation. Cancer Lett 267: 165-174, 2008.
164. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the human genome. Nature 409: 860-921, 2001. (Pubitemid 32165345)
165. Landry J, Slama JT, and Sternglanz R. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochem Biophys Res Commun 278: 685-690, 2000.
166. Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, and Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A 97: 5807-5811, 2000. (Pubitemid 30367480)
167. Latini A, da Silva CG, Ferreira GC, Schuck PF, Scussiato K, Sarkis JJ, Dutra Filho CS, Wyse AT, Wannmacher CM, and Wajner M. Mitochondrial energy metabolism is markedly impaired by D-2-hydroxyglutaric acid in rat tissues. Mol Genet Metab 86: 188-199, 2005. (Pubitemid 41412175)
168. Latini A, Scussiato K, Rosa RB, Leipnitz G, Llesuy S, Bello-Klein A, Dutra-Filho CS, and Wajner M. Induction of oxidative stress by L-2-hydroxyglutaric acid in rat brain. J Neurosci Res 74: 103-110, 2003. (Pubitemid 37176673)
169. Latini A, Scussiato K, Rosa RB, Llesuy S, Bello-Klein A, Dutra-Filho CS, and Wajner M. D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur J Neurosci 17: 2017-2022, 2003. (Pubitemid 36713962)
170. Lawless MW, Norris S, O'Byrne KJ, and Gray SG. Targeting histone deacetylases for the treatment of disease. J Cell Mol Med 13: 826-852, 2009.
171. Lee BC, Dikiy A, Kim HY, and Gladyshev VN. Functions and evolution of selenoprotein methionine sulfoxide reductases. Biochim Biophys Acta 1790: 1471-1477, 2009.
172. Leeb M, Steffen PA, and Wutz A. X chromosome inactivation sparked by non-coding RNAs. RNA Biol 6: 94-99, 2009.
173. Lei KF, Wang YF, Zhu XQ, Lu PC, Sun BS, Jia HL, Ren N, Ye QH, Sun HC, Wang L, et al. Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma. BMC Cancer 7: 172, 2007.
174. Lertratanangkoon K, Orkiszewski RS, and Scimeca JM. Methyl-donor deficiency due to chemically induced glutathione depletion. Cancer Res 56: 995-1005, 1996. (Pubitemid 26065392)
175. Lertratanangkoon K, Savaraj N, Scimeca JM, and Thomas ML. Glutathione depletion-induced thymidylate insufficiency for DNA repair synthesis. Biochem Biophys Res Commun 234: 470-475, 1997. (Pubitemid 27243927)
176. Lertratanangkoon K, Wu CJ, Savaraj N, and Thomas ML. Alterations of DNA methylation by glutathione depletion. Cancer Lett 120: 149-156, 1997. (Pubitemid 27496811)
177. Levine M, Espey MG, and Chen Q. Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment. Free Radic Biol Med 47: 27-29, 2009.
178. Li Q, Ke Q, and Costa M. Alterations of histone modifications by cobalt compounds. Carcinogenesis 30: 1243-1251, 2009.
179. Liang G, Lin JC, Wei V, Yoo C, Cheng JC, Nguyen CT, Weisenberger DJ, Egger G, Takai D, Gonzales FA, et al. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc Natl Acad Sci U S A 101: 7357-7362, 2004. (Pubitemid 38638037)
180. Lin SJ, Defossez PA, and Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128, 2000.
181. Lin SJ and Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol 15: 241-246, 2003. (Pubitemid 36332200)
182. Lin SJ, Kaeberlein M, Andalis AA, Sturtz LA, Defossez PA, Culotta VC, Fink GR, and Guarente L. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 418: 344-348, 2002. (Pubitemid 34790687)
183. Lin Y, Liu X, Cheng Y, Yang J, Huo Y, and Zhang C. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem 284: 7903-7913, 2009.
184. Liu H, Hu Q, D'Ercole AJ, and Ye P. Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells. Glia 57: 1-12, 2009.
185. * targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 29: 4914-4924, 2010.
186. Liu Y, Borchert GL, Donald SP, Surazynski A, Hu CA, Weydert CJ, Oberley LW, and Phang JM. MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis 26: 1335-1342, 2005. (Pubitemid 41417875)
187. Liu Y, Borchert GL, Surazynski A, and Phang JM. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene 27: 6729-6737, 2008.
188. Lu SC. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 13: 1169-1183, 1999. (Pubitemid 29300363)
189. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 30: 42-59, 2009.
190. Lukiw WJ and Pogue AI. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem 101: 1265-1269, 2007. (Pubitemid 47313522)
191. MacKenzie ED, Selak MA, Tennant DA, Payne LJ, Crosby S, Frederiksen CM, Watson DG, and Gottlieb E. Cellpermeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol 27: 3282-3289, 2007. (Pubitemid 46685207)
192. Malecova B and Morris KV. Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs. Curr Opin Mol Ther 12: 214-222, 2010.
193. Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrozek K, Margeson D, Holland KB, Whitman SP, Becker H, Schwind S, et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within De Novo cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 28: 2348-2355, 2010.
194. Marmorstein R and Roth SY. Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev 11: 155-161, 2001. (Pubitemid 32209199)
195. Martin M, Kettmann R, and Dequiedt F. Class IIa histone deacetylases: regulating the regulators. Oncogene 26: 5450-5467, 2007. (Pubitemid 47255927)
196. Mastroeni D, McKee A, Grover A, Rogers J, and Coleman PD. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS ONE 4: e6617, 2009.
197. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466: 253-257, 2010.
198. Maxwell P and Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther 3: 29-35, 2004. (Pubitemid 41342413)
199. Maxwell SA and Kochevar GJ. Identification of a p53-response element in the promoter of the proline oxidase gene. Biochem Biophys Res Commun 369: 308-313, 2008.
200. McNeill LA, Flashman E, Buck MR, Hewitson KS, Clifton IJ, Jeschke G, Claridge TD, Ehrismann D, Oldham NJ, and Schofield CJ. Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. Mol Biosyst 1: 321-324, 2005. (Pubitemid 41579324)
201. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 263: 17205-17208, 1988. (Pubitemid 19029311)
202. Meister A and Anderson ME. Glutathione. Annu Rev Biochem 52: 711-760, 1983. (Pubitemid 13030692)
203. Messner S, Altmeyer M, Zhao H, Pozivil A, Roschitzki B, Gehrig P, Rutishauser D, Huang D, Caflisch A, and Hottiger MO. PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic Acids Res 38: 6350-6362, 2010.
204. Metzen E, Zhou J, Jelkmann W, Fandrey J, and Brune B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell 14: 3470-3481, 2003. (Pubitemid 37013142)
205. Meyron-Holtz EG, Vaisman B, Cabantchik ZI, Fibach E, Rouault TA, Hershko C, and Konijn AM. Regulation of intracellular iron metabolism in human erythroid precursors by internalized extracellular ferritin. Blood 94: 3205-3211, 1999. (Pubitemid 29512730)
206. Mikirova NA, Casciari JJ, and Riordan NH. Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo. J Angiogenes Res 2: 2, 2010.
207. Miller G. Epigenetics. The seductive allure of behavioral epigenetics. Science 329: 24-27, 2010.
208. Mitro N, Godio C, De Fabiani E, Scotti E, Galmozzi A, Gilardi F, Caruso D, Vigil Chacon AB, and Crestani M. Insights in the regulation of cholesterol 7alpha-hydroxylase gene reveal a target for modulating bile acid synthesis. Hepatology 46: 885-897, 2007. (Pubitemid 47436134)
209. Mongan PD, Capacchione J, West S, Karaian J, Dubois D, Keneally R, and Sharma P. Pyruvate improves redox status and decreases indicators of hepatic apoptosis during hemorrhagic shock in swine. Am J Physiol Heart Circ Physiol 283: H1634-H1644, 2002.
210. Moodie FM, Marwick JA, Anderson CS, Szulakowski P, Biswas SK, Bauter MR, Kilty I, and Rahman I. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J 18: 1897-1899, 2004. (Pubitemid 39602276)
211. Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, and Smith MA. Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 1802: 212-220, 2010.
212. Morey L and Helin K. Polycomb group protein-mediated repression of transcription. Trends Biochem Sci 35: 323-332, 2010.
213. Moroni I, Bugiani M, D'Incerti L, Maccagnano C, Rimoldi M, Bissola L, Pollo B, Finocchiaro G, and Uziel G. L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology 62: 1882-1884, 2004. (Pubitemid 38661759)
214. Mosammaparast N and Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 79: 155-179, 2010.
215. Muckenthaler MU, Galy B, and Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr 28: 197-213, 2008.
216. Mueller S. Iron regulatory protein 1 as a sensor of reactive oxygen species. Biofactors 24: 171-181, 2005. (Pubitemid 41750540)
217. Murayama A, Ohmori K, Fujimura A, Minami H, Yasuzawa-Tanaka K, Kuroda T, Oie S, Daitoku H, Okuwaki M, Nagata K, et al. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 133: 627-639, 2008. (Pubitemid 351636301)
218. Nakayama J, Rice JC, Strahl BD, Allis CD, and Grewal SI. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292: 110-113, 2001. (Pubitemid 32289138)
219. Ng SS, Kavanagh KL, McDonough MA, Butler D, Pilka ES, Lienard BM, Bray JE, Savitsky P, Gileadi O, von Delft F, et al. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448: 87-91, 2007. (Pubitemid 47037008)
220. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767, 2001. (Pubitemid 32678256)
221. Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, and Smith MA. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 59: 1011-1017, 2000.
222. Nusinow DA, Hernandez-Munoz I, Fazzio TG, Shah GM, Kraus WL, and Panning B. Poly(ADP-ribose) polymerase 1 is inhibited by a histone H2A variant, MacroH2A, and contributes to silencing of the inactive X chromosome. J Biol Chem 282: 12851-12859, 2007. (Pubitemid 47100579)
223. Obrosova I, Faller A, Burgan J, Ostrow E, and Williamson JR. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor. Curr Eye Res 16: 34-43, 1997. (Pubitemid 27085150)
224. Obrosova IG and Stevens MJ. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest Ophthalmol Vis Sci 40: 680-688, 1999. (Pubitemid 29109446)
225. Ohno S, Ohno Y, Suzuki N, Soma G, and Inoue M. Highdose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer. Anticancer Res 29: 809-815, 2009.
226. Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, and Lange AJ. PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26: 30-35, 2001. (Pubitemid 32124707)
227. Ooi SK and Bestor TH. The colorful history of active DNA demethylation. Cell 133: 1145-1148, 2008. (Pubitemid 351852922)
228. Ordovas JM and Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 7: 510-519, 2010.
229. Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, et al. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res 7: R669-R680, 2005.
230. Otake H, Miwa M, Fujimura S, and Sugimura T. Binding of ADP-ribose polymer with histone. J Biochem 65: 145-146, 1969.
231. Ozdemir A, Masumoto H, Fitzjohn P, Verreault A, and Logie C. Histone H3 lysine 56 acetylation: a new twist in the chromosome cycle. Cell Cycle 5: 2602-2608, 2006. (Pubitemid 44785804)
232. Ozer A and Bruick RK. Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat Chem Biol 3: 144-153, 2007.
233. Ozisik PA, Akalan N, Palaoglu S, and Topcu M. Medulloblastoma in a child with the metabolic disease L-2-hydroxyglutaric aciduria. Pediatr Neurosurg 37: 22-26, 2002. (Pubitemid 34920739)
234. Paik WK and Kim S. Enzymatic demethylation of calf thymus histones. Biochem Biophys Res Commun 51: 781-788, 1973.
235. Pal-Bhadra M, Bhadra U, Jackson DE, Mamatha L, Park PH and Shukla SD. Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes. Life Sci 81: 979-987, 2007. (Pubitemid 47384784)
236. Pan Y, Mansfield KD, Bertozzi CC, Rudenko V, Chan DA, Giaccia AJ, and Simon MC. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 27: 912-925, 2007. (Pubitemid 46174556)
237. Pandhare J, Cooper SK, and Phang JM. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. J Biol Chem 281: 2044-2052, 2006. (Pubitemid 43845792)
238. Pardanani A, Lasho TL, Finke CM, Mai M, McClure RF, and Tefferi A. IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. Leukemia 24: 1146-1151, 2010.
239. Park PH, Miller R, and Shukla SD. Acetylation of histone H3 at lysine 9 by ethanol in rat hepatocytes. Biochem Biophys Res Commun 306: 501-504, 2003. (Pubitemid 36683102)
240. Park PJ. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet 10: 669-680, 2009.
241. Pasini B and Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 266: 19-42, 2009.
242. Passos JF, Saretzki G, Ahmed S, Nelson G, Richter T, Peters H, Wappler I, Birket MJ, Harold G, Schaeuble K, et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 5: e110, 2007.
243. Passos JF, von Zglinicki T, and Saretzki G. Mitochondrial dysfunction and cell senescence: cause or consequence? Rejuvenation Res 9: 64-68, 2006.
244. Pearce LL, Martinez-Bosch S, Manzano EL, Winnica DE, Epperly MW, and Peterson J. The resistance of electrontransport chain Fe-S clusters to oxidative damage during the reaction of peroxynitrite with mitochondrial complex II and rat-heart pericardium. Nitric Oxide 20: 135-142, 2009.
245. Peters AH, Mermoud JE, O'Carroll D, Pagani M, Schweizer D, Brockdorff N, and Jenuwein T. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat Genet 30: 77-80, 2002.
246. Phang JM, Donald SP, Pandhare J, and Liu Y. The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids 35: 681-690, 2008.
247. Picard V, Epsztejn S, Santambrogio P, Cabantchik ZI, and Beaumont C. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J Biol Chem 273: 15382-15386, 1998. (Pubitemid 28298142)
248. Pillai JB, Isbatan A, Imai S, and Gupta MP. Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J Biol Chem 280: 43121-43130, 2005. (Pubitemid 43049278)
249. Piper PW, Harris NL, and MacLean M. Preadaptation to efficient respiratory maintenance is essential both for maximal longevity and the retention of replicative potential in chronologically ageing yeast. Mech Ageing Dev 127: 733-740, 2006. (Pubitemid 44188818)
250. Pourazar J, Mudway IS, Samet JM, Helleday R, Blomberg A, Wilson SJ, Frew AJ, Kelly FJ, and Sandstrom T. Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways. Am J Physiol Lung Cell Mol Physiol 289: L724-L730, 2005. (Pubitemid 41504403)
251. Powell CS and Jackson RM. Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD. Am J Physiol Lung Cell Mol Physiol 285: L189-L198, 2003. (Pubitemid 36736482)
252. Quenet D, El Ramy R, Schreiber V, and Dantzer F. The role of poly(ADP-ribosyl)ation in epigenetic events. Int J Biochem Cell Biol 41: 60-65, 2009.
253. Radtke F, Hug M, Georgiev O, Matsuo K, and Schaffner W. Differential sensitivity of zinc finger transcription factors MTF-1, Sp1 and Krox-20 to CpG methylation of their binding sites. Biol Chem Hoppe Seyler 377: 47-56, 1996. (Pubitemid 26056833)
254. Ramasamy R, TruebloodN, and Schaefer S. Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion. Am J Physiol 275(1 Pt 2): H195-H203, 1998.
255. Rich PR. The molecular machinery of Keilin's respiratory chain. Biochem Soc Trans 31(Pt 6): 1095-1105, 2003. (Pubitemid 38030918)
256. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323, 2007. (Pubitemid 46962090)
257. Ristoff E and Larsson A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2: 16, 2007.
258. Rivera A and Maxwell SA. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem 280: 29346-29354, 2005. (Pubitemid 41161390)
259. Roth SY, Denu JM, and Allis CD. Histone acetyl-transferases. Annu Rev Biochem 70: 81-120, 2001.
260. Rouleau M, Aubin RA, and Poirier GG. Poly(ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci 117(Pt 6): 815-825, 2004. (Pubitemid 38386940)
261. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, and Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10: 293-301, 2010.
262. Russell RR 3rd, Mommessin JI, and Taegtmeyer H. Propionyl-L-carnitine- mediated improvement in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol 268(1 Pt 2): H441-H447, 1995.
263. Russell RR 3rd and Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol 261(6 Pt 2): H1756-H1762, 1991.
264. Rzem R, Veiga-da-Cunha M, Noel G, Goffette S, Nassogne MC, Tabarki B, Scholler C, Marquardt T, Vikkula M, and Van Schaftingen E. A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101: 16849-16854, 2004. (Pubitemid 39601327)
265. Rzem R, Vincent MF, Van Schaftingen E, and Veigada-Cunha M. L-2-hydroxyglutaric aciduria, a defect of metabolite repair. J Inherit Metab Dis 30: 681-689, 2007. (Pubitemid 47559879)
266. Salahudeen AA and Bruick RK. Maintaining Mammalian iron and oxygen homeostasis: sensors, regulation, and cross-talk. Ann N Y Acad Sci 1177: 30-38, 2009.
267. Salminen A and Kaarniranta K. SIRT1 regulates the ribosomal DNA locus: epigenetic candles twinkle longevityinthe Christmas tree. Biochem Biophys Res Commun 378: 6-9, 2009.
268. Salnikow K, An WG, Melillo G, Blagosklonny MV, and Costa M. Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis 20: 1819-1823, 1999. (Pubitemid 29410563)
269. Salnikow K, Blagosklonny MV, Ryan H, Johnson R, and Costa M. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res 60: 38-41, 2000. (Pubitemid 30058726)
270. Sandmeier JJ, Celic I, Boeke JD and Smith JS. Telomeric and rDNA silencing in Saccharomyces cerevisiae are dependent on a nuclear NAD(+) salvage pathway. Genetics 160: 877-889, 2002. (Pubitemid 34263455)
271. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, Schreiber SL, Mellor J, and Kouzarides T. Active genes are tri-methylated at K4 of histone H3. Nature 419: 407-411, 2002.
272. Santos-Rosa H, Schneider R, Bernstein BE, Karabetsou N, Morillon A, Weise C, Schreiber SL, Mellor J, and Kouzarides T. Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin. Mol Cell 12: 1325-1332, 2003. (Pubitemid 37487939)
273. Sawant RR, Vaze O, Rockwell K, and Torchilin VP. Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. Eur J Pharm Biopharm 75: 321-326, 2010.
274. Saxonov S, Berg P, and Brutlag DL. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A 103: 1412-1417, 2006. (Pubitemid 43191179)
275. Schaefer M and Lyko F. Solving the Dnmt2 enigma. Chromosoma 119: 35-40, 2010.
276. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, and Kouzarides T. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6: 73-77, 2004. (Pubitemid 38425733)
277. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, and Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7: 77-85, 2005. (Pubitemid 40126384)
278. Selak MA, Duran RV, and Gottlieb E. Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells. Biochim Biophys Acta 1757: 567-572, 2006. (Pubitemid 43993873)
279. Sharma P, Kumar J, Garg G, Kumar A, Patowary A, Karthikeyan G, Ramakrishnan L, Brahmachari V, and Sengupta S. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 27: 357-365, 2008. (Pubitemid 351969854)
280. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, and Casero RA. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119: 941-953, 2004. (Pubitemid 40037608)
281. Shore D, Squire M, and Nasmyth KA. Characterization of two genes required for the position-effect control of yeast mating-type genes. EMBO J 3: 2817-2823, 1984.
282. Siedlecki P and Zielenkiewicz P. Mammalian DNA methyltransferases. Acta Biochim Pol 53: 245-256, 2006. (Pubitemid 44033922)
283. Smith BC and Denu JM. Chemical mechanisms of histone lysine and arginine modifications. Biochim Biophys Acta 1789: 45-57, 2009.
284. Smith BC, Hallows WC, and Denu JM. Mechanisms and molecular probes of sirtuins. Chem Biol 15: 1002-1013, 2008.
285. Smith EH, Janknecht R, and Maher LJ 3rd. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma. Hum Mol Genet 16: 3136-3148, 2007. (Pubitemid 350131331)
286. Smith JS, Brachmann CB, Celic I, Kenna MA, Muhammad S, Starai VJ, Avalos JL, Escalante-Semerena JC, Grubmeyer C, Wolberger C, et al. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci U S A 97: 6658-6663, 2000. (Pubitemid 30412770)
287. Somoza JR, Skene RJ, Katz BA, Mol C, Ho JD, Jennings AJ, Luong C, Arvai A, Buggy JJ, Chi E, et al. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12: 1325-1334, 2004. (Pubitemid 38900774)
288. Spannhoff A, Hauser AT, Heinke R, Sippl W, and Jung M. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors. ChemMedChem 4: 1568-1582, 2009.
289. Strahl BD, Ohba R, Cook RG, and Allis CD. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci U S A 96: 14967-14972, 1999. (Pubitemid 30019748)
290. Struys EA. D-2-Hydroxyglutaric aciduria: unravelling the biochemical pathway and the genetic defect. J Inherit Metab Dis 29: 21-29, 2006.
291. Struys EA, Verhoeven NM, Jansen EE, Ten Brink HJ, Gupta M, Burlingame TG, Quang LS, Maher T, Rinaldo P, Snead OC, et al. Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase. Metabolism 55: 353-358, 2006. (Pubitemid 43234389)
292. Su WY, Xiong H, and Fang JY. Natural antisense transcripts regulate gene expression in an epigenetic manner. Biochem Biophys Res Commun 396: 177-181, 2010.
293. Sun H, Zhou X, Chen H, Li Q, and Costa M. Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicol Appl Pharmacol 237: 258-266, 2009.
294. Sunden SL, Renduchintala MS, Park EI, Miklasz SD, and Garrow TA. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys 345: 171-174, 1997. (Pubitemid 27374220)
295. Suzuki MM and Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9: 465-76, 2008. (Pubitemid 351693975)
296. Szent-Györgyi A. Electronic Biology and Cancer: A New Theory of Cancer. New York, NY: Marcel Dekker, 1976.
297. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by the MLL Fusion Partner TET1. Science 324: 930-935, 2009.
298. Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J, and Higashinakagawa T. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 9: 1211-1222, 1995.
299. Tal TL, Simmons SO, Silbajoris R, Dailey L, Cho SH, Ramabhadran R, Linak W, Reed W, Bromberg PA, and Samet JM. Differential transcriptional regulation of IL-8 expression by human airway epithelial cells exposed to diesel exhaust particles. Toxicol Appl Pharmacol 243: 46-54, 2010.
300. Tanner KG, Landry J, Sternglanz R, and Denu JM. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci U S A 97: 14178-14182, 2000. (Pubitemid 32016550)
301. Tanny JC, Dowd GJ, Huang J, Hilz H, and Moazed D. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell 99: 735-745, 1999. (Pubitemid 30017644)
302. Theil EC and Goss DJ. Living with iron (and oxygen): questions and answers about iron homeostasis. Chem Rev 109: 4568-4579, 2009.
303. Thompson PR and Fast W. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? ACS Chem Biol 1: 433-441, 2006.
304. Tomasetti M, Strafella E, Staffolani S, Santarelli L, Neuzil J, and Guerrieri R. alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate. Br J Cancer 102: 1224-1234, 2010.
305. Tretter L and Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci 360: 2335-2345, 2005. (Pubitemid 46682153)
306. Trewick SC, Henshaw TF, Hausinger RP, Lindahl T, and Sedgwick B. Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature 419: 174-178, 2002. (Pubitemid 35025446)
307. Trewick SC, McLaughlin PJ, and Allshire RC Methylation: lost in hydroxylation? EMBO Rep 6: 315-320, 2005. (Pubitemid 40561622)
308. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, and Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439: 811-816, 2006. (Pubitemid 43255695)
309. Tulin A, Chinenov Y, and Spradling A. Regulation of chromatin structure and gene activity by poly(ADP-ribose) polymerases. Curr Top Dev Biol 56: 55-83, 2003. (Pubitemid 137639483)
310. Tulin A, Naumova NM, Menon AK, and Spradling AC. Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing. Genetics 172: 363-371, 2006. (Pubitemid 43345498)
311. Tulin A and Spradling A. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 299: 560-562, 2003. (Pubitemid 36135152)
312. Turunen MP, Aavik E, and Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta 1790: 886-891, 2009.
313. Ueda K, Omachi A, Kawaichi M, and Hayaishi O. Natural occurrence of poly(ADP-ribosyl) histones in rat liver. Proc Natl Acad Sci U S A 72: 205-209, 1975.
314. Ueda R, Suzuki T, Mino K, Tsumoto H, Nakagawa H, Hasegawa M, Sasaki R, Mizukami T, and Miyata N. Identification of cell-active lysine specific demethylase 1-selective inhibitors. J Am Chem Soc 131: 17536-17537, 2009.
315. Van Schaftingen E, Rzem R, and Veiga-da-Cunha M. L: - 2-hydroxyglutaric aciduria, a disorder of metabolite repair. J Inherit Metab Dis 32: 135-142, 2009.
316. Vander Heiden MG, Cantley LC, and Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033, 2009.
317. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695-1699, 2008.
318. Villagra A, Cheng F, Wang HW, Suarez I, Glozak M, Maurin M, Nguyen D, Wright KL, Atadja PW, Bhalla K, et al. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat Immunol 10: 92-100, 2009.
319. Vissers MC and Wilkie RP. Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1alpha. J Leukoc Biol 81: 1236-1244, 2007. (Pubitemid 46702042)
320. Waddington CH. The epigenetics of birds. Cambridge, UK: Cambridge University Press, 1952.
321. Wade PA, Pruss D, and Wolffe AP. Histone acetylation: chromatin in action. Trends Biochem Sci 22: 128-132, 1997. (Pubitemid 27156942)
322. Wamelink MM, Struys EA, and Jakobs C. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis 31: 703-717, 2008.
323. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306: 279-283, 2004. (Pubitemid 39336873)
324. Warburg O. On the origin of cancer cells. Science 123: 309-314, 1956.
325. Warburg O, Posener K, and Negelein E. Onthe metabolism of carcinoma cells. Biochemische Zeitschrift 152: 309-344, 1924.
326. This reference has been deleted.
327. Wen YD, Perissi V, Staszewski LM, Yang WM, Krones A, Glass CK, Rosenfeld MG, and Seto E. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci U S A 97: 7202-7207, 2000. (Pubitemid 30431441)
328. Wiesen JL and Tomasi TB. Dicer is regulated by cellular stresses and interferons. Mol Immunol 46: 1222-1228, 2009.
329. Witt O, Deubzer HE, Milde T, and Oehme I. HDAC family: what are the cancer relevant targets? Cancer Lett 277: 8-21, 2009.
330. Wnek SM, Jensen TJ, Severson PL, Futscher BW, and Gandolfi AJ. Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci 116: 44-57, 2010.
331. Wysocka J, Allis CD, and Coonrod S. Histone arginine methylation and its dynamic regulation. Front Biosci 11: 344-355, 2006. (Pubitemid 43253497)
332. Yamakuchi M, Ferlito M, and Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 105: 13421-13426, 2008.
333. Yan Y, Kluz T, Zhang P, Chen HB, and Costa M. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. Toxicol Appl Pharmacol 190: 272-277, 2003. (Pubitemid 36937217)
334. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, and Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 291: L46-L57, 2006.
335. Ye H and Rouault TA. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 49: 4945-4956, 2010.
336. Yideng J, Jianzhong Z, Ying H, Juan S, Jinge Z, Shenglan W, Xiaoqun H, and Shuren W. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol 26: 603-611, 2007. (Pubitemid 47263207)
337. Yideng J, Zhihong L, Jiantuan X, Jun C, Guizhong L, and Shuren W. Homocysteine-mediated PPARalpha, gamma DNA methylation and its potential pathogenic mechanism in monocytes. DNA Cell Biol 27: 143-150, 2008. (Pubitemid 351457770)
338. Yuan J, Pu M, Zhang Z, and Lou Z. Histone H3-K56 acetylation is important for genomic stability in mammals. Cell Cycle 8: 1747-1753, 2009.
339. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health 29: 245-254, 2006.
340. Zardo G and Caiafa P. The unmethylated state of CpG islands in mouse fibroblasts depends on the poly(ADP-ribosyl)ation process. J Biol Chem 273: 16517-16520, 1998. (Pubitemid 28311436)
341. Zardo G, Marenzi S, Perilli M, and Caiafa P. Inhibition of poly(ADP-ribosyl)ation introduces an anomalous methylation pattern in transfected foreign DNA. FASEB J 13: 1518-1522, 1999. (Pubitemid 29411784)
342. Zardo G, Reale A, De Matteis G, Buontempo S, and Caiafa P. A role for poly(ADP-ribosyl)ation in DNA methylation. Biochem Cell Biol 81: 197-208, 2003. (Pubitemid 37076242)
343. Zardo G, Reale A, Passananti C, Pradhan S, Buontempo S, De Matteis G, Adams RL, and Caiafa P. Inhibition of poly(ADP-ribosyl)ation induces DNA hypermethylation: a possible molecular mechanism. FASEB J 16: 1319-1321, 2002.
344. Zawia NH, Lahiri DK, and Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med 46: 1241-1249, 2009.
345. Zhang AS and Enns CA. Molecular mechanisms of normal iron homeostasis. Hematol Am Soc Hematol Educ Program 207-214, 2009.
346. Zhang J. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? Bioessays 25: 808-814, 2003. (Pubitemid 36966382)
347. Zhang Q, Piston DW, and Goodman RH. Regulation of corepressor function by nuclear NADH. Science 295: 1895-1897, 2002. (Pubitemid 34214127)
348. Zhang T, Berrocal JG, Frizzell KM, Gamble MJ, DuMond ME, Krishnakumar R, Yang T, Sauve AA, and Kraus WL. Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem 284: 20408-20417, 2009.
349. Zhang Y, Marcillat O, Giulivi C, Ernster L, and Davies KJ. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 265: 16330-16336, 1990.
350. Zhang Z, Ren J, Harlos K, McKinnon CH, Clifton IJ, and Schofield CJ. Crystal structure of a clavaminate synthase-Fe(II)-2-oxoglutarate-substrate-NO complex: evidence for metal centered rearrangements. FEBS Lett 517: 7-12, 2002. (Pubitemid 34327621)
351. Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324: 261-265, 2009.
352. Zhou X, Li Q, Arita A, Sun H, and Costa M. Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol 236: 78-84, 2009.
353. Zhu JK. Active DNA demethylation mediated by DNA glycosylases. Annu Rev Genet 43: 143-166, 2009.